Keywords : non-urothelial bladder cancer
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 6, Pages 479-484
Aim: The aim of the present study to evaluate the oncologic prognoses of people with nonurothelial bladder cancer.
Material and methods: This prospective observational study was carried out after being given the all-clear by the protocol review committee and the institutional ethics committee. Twenty-two adults were included in the study because they all had histologically confirmed NUBCs.
Results: Twenty-two people who had NUBCs participated in this study. Adenocarcinoma was found in 12 of them, whereas Squamous Cell Carcinoma was in 5, small cell carcinoma in 3, and inflammatory myofibroblastic cancer in 2. The patients' median age at presentation was 53.55 years, and 19 of them (86.36%) presented with hematuria as their primary complaint. Two people reported soreness in the lower urinary tract. The majority of patients were diagnosed at T3, and just one had advanced cancer.
Conclusion: Rare uveo-uveal biliary cancer (NUBC) exhibits several histological variants. We conclude that NUBC is a very aggressive disease with a poor prognosis since it is often diagnosed late in the course of the disease. The courses of therapy vary. To improve long-term survival rates, we need a concerted effort from institutions all around the world to shed light on the biology of these cancers and evaluate current treatment methods